Glutamate receptors Flashcards

1
Q

Metabotropic glutamate receptors Group I

A
  • mGluR1, mGluR5
  • Gq → PLC, Ca2+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Metabotropic glutamate receptors Group II

A

mGluR2, mGluR3
* Gi → ↓ cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metabotropic glutamate receptors Group III

A

mGluR4, mGluR6, mGluR7, mGluR8
* Gi → ↓ cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Group I mGluR found mostly

A

postsynaptically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Group II and III are often found

A

presynaptically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Group II and III are often found presynaptically

A

Autoreceptors
* Modulators on other NT systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Metabotropic glutamate receptors Contribute to

A

plasticity of synapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metabotropic glutamate receptors Excitatory or inhibitory depending on

A

signalling, cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Knockout studies mGluR1 KO show

A

motor dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mGluR1 KO show motor dysfunction

A

Ataxia, intention tremor, dysmetria
* Impaired plasticity in the cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • mGluR2 KO show
A

normal synaptic
transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

mGluR2 KO show normal synaptic
transmission

A

Highly expressed in dentate gyrus
* KO shows reduced presynaptic inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Receptor
distribution At postsynaptic densities mGluR
are expressed at the

A

periphery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Receptor
distribution AMPAR and NMDAR are
distributed

A

throughout the PSD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Receptor
distribution NMDAR are

A

tightly coupled to
Ca2+
-dependent proteins such as
CaMKII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Plasticity Hippocampus

A
  • Important for learning and
    memory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Plasticity Synaptic plasticity

A

Changes in strength of
glutamatergic synapses in
response to activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Plasticity LTP

A

persistent increase in synaptic
strength following tetanic
activity (100 Hz, 1 s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Plasticity * Long-term depression (LTD)

A

persistent decrease in
synaptic strength following
slow repetitive activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Plasticity in the HC

A

Hippocampal plasticity is widely
studied due to the role in learning
and the well defined circuits (most
glutamatergic).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LTP occurs through

A

coincidence detection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CaMKII is coupled to

A

NMDAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ca2+-calmodulin dependent
protein kinase II (CamKII) Localizes with NMDA receptors
(intracellular face)

A

Phosphorylates numerous
cellular targets and initiates
early-phase of LTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

LTP and glutamate

A

repeated stimulation very quickly - repeated activation of AMPA receptors causes depolarization across membrane - allows MG to be removed from NMDA receptor - calium flows in - result is LTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
early-phase of LTP Ca2+
entry through NMDAR activates CamKII
26
Early LTP CamKII
phorphorylates AMPAR – increasing their sensitivity to glutamate
27
Early LTP CamKII phorphorylates AMPAR – increasing their sensitivity to glutamate. Signalling cascades
increase trafficking of AMPAR to the postsynaptic density – increasing the availability of receptors.
28
Early LTP Ca2+ -entry through NMDAR activates CamKII . CamKII phorphorylates AMPAR – increasing their sensitivity to glutamate. Signalling cascades increase trafficking of AMPAR to the postsynaptic density – increasing the availability of receptors. Retrograde messengers
signal to the presynaptic cell initiating presynaptic changes that increase glutamate release.
29
Late-phase LTP Activation of CamKII and PLC converge on another signalling kinase
ERK
30
Late-phase LTP ERK triggers downstream changes including phosphorylation of transcription factors
Gene synthesis is induced increasing production of AMPA receptors
31
Synthesis processes are important for
long-term maintenance of potentiation
32
NMDA receptors and LTP NMDAR overexpression increases
learning in mice
33
Mice engineered to overexpress the NR2B subunit * Termed Doogie mouse… * Increased
retention in novel object recognition tasks
34
Excitotoxicity Glutamate and excitatory analogues can be
neurotoxic specifically when extracellularly
35
MSG can induce
lesions
36
lesions can be induces by other
agonists of the glutamate receptor
37
Excitotoxicity Occurs through
over activation of glutamatergic neurons
38
Excitotoxicity Increased intracellular
Ca2+ to dangerous levels
39
Increased intracellular Ca2+ to dangerous levels Contributes to (6)
pathogenesis of ischemia, ALS, traumatic brain injury, alcoholism, Huntington’s disease, multiple sclerosis
40
Lytigo-bodig disease is a
neurodegenerative disease that manifests similar to ALS and Parkinson’s
41
Lytigo-bodig disease is Localized in
Guam
42
Local cycad seeds (Cyas circinalis) contain
BMAA
43
BMAA potent
excitotoxin at AMPA, kainate, and NMDA receptors
44
* A mutation found in ALS patients leads to increased
intracellular Ca2+ in motor neurons, which stresses mitochondria. Mitochondria produce reactive oxygen species (ROS) that are toxic and also inhibit EAAT2 on astrocytes
45
EAAT2 dysfunction leads to
glutamate accumulation and excitotoxicity in motor neurons.
46
Ischemia
* Ischemic stroke results in loss of blood flow to regions of the CNS
47
Ischemia Lack of O2 and glucose causes
energy failure
48
Ischemia Loss of ionic gradients causes
glutamatergic synapses to dump glutamate
49
Loss of ionic gradients causes glutamatergic synapses to dump glutamate
ncreased intracellular Ca2+ Failure of EAAT transport (depends on ion gradient) reverses glutamate flow
50
Excitotoxic cell death Necrosis
Uncontrolled cell death
51
Necrosis process
* Na+ and Cl influx to cell causes hypertonicity -Osmosis causes cell swelling (edema) -Swelling leads to rupture of the cell membrane and cell lysis
52
Excitotoxic cell death Apoptosis
Programmed cell death
53
Apoptosis Process
Ca2+ influx activates intracellular pathways - Mitochondrial generation of ROS • Depolarization and swelling of mitochondria Mitochondrial damage leads to formation of pores in mitochondrial membrane • Cytochrome C escapes • Initiates apoptosis
54
Two modes of cell death are initiated
by ischemic / glutamatergic injury
55
Apoptosis is regulated cell death and results in
controlled removal of cell material by phagocytic cells.
56
Necrosis results in cell lysis and
release of cellular contents.
57
Glutamatergic cell death In animal models, NMDA or AMPA antagonists reduce the volume of injury in
n ischemic stroke
58
Glutamatergic cell death - Glutamate can cause
over-excitation leading to cell death by necrosis or apoptosis → Excitotoxicity
59
Epileptiform activity Epilepsy
Heterogeneous group of neurological disorders characterized by epileptic seizures
60
* Epilepsy Abnormal
excessive or synchronous neuronal activity in the brain
61
Epilepsy and glutamatergic activity
Epileptic seizures are dependent on glutamatergic signalling
62
* Pharmacological activation of glutamatergic signalling can initiate
seizures in animal models
63
convulsant
Kainate, AMPA, domoic acid are convulsants
64
Early seizure activity is dependent on
AMPA receptor activation
65
Antagonists of AMPAR can
prevent seizure onset (e.g. NBQX
66
As seizures intensify and spread
NMDA receptors are involved
67
Antagonists of NMDAR can reduce
Intensity and duration of seizures (e.g. MK801)
68
Genetic causes of epilepsy * Glutamatergic changes are found in many heritable cases of epilepsy -
Heterogeneous
69
Genetic causes of epilepsy - Glutamate receptors
AMPA, kainate, and NMDA receptor subunits altered
70
Genetic causes of epilepsy -Glutamate transporters
* EAAT 1 and 2 show alterations in patients
71
Genetic causes of epilepsy - Astrocytic glutamate recycling
Glutamine synthetase, glutamate dehydrogenase
72
Epilepsy treatment (AEDs)
Anticonvulsants/antiepileptic drugs (AEDs) are one of the few drug classes that is not tested against placebo
73
AEDs typically target
et Na+ channel activity or increase inhibitory signalling by affecting GABA
74
* 30% of patients are unresponsive to
AED therapy
75
AEDs often lose
effectiveness over time
76
Surgical resection of seizure focus remains a
common treatment of drug-resistant epilepsy
77
Corpus callostomy
Corpus callostomy is effective at decreasing the frequency and amplitude of seizures by disrupting bilateral synchronous discharges.
78
Corpus callostomy Side effects
s include speech irregularities – inability to engage in spontaneous speech, inability to follow verbal commands using non-dominant hand, and alien hand syndrome